Changes in Acid Base Status During High Salt Intake

NCT ID: NCT01655953

Last Updated: 2012-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

8 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-07-31

Study Completion Date

2007-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aimed to examine the effects of an alkalinisation of a NaCl (sodium chloride, salt)-rich diet on acid base status, bone metabolism, protein turnover and other influenced physiological systems. Due to increased urinary calcium excretion and bone resorption a high NaCl-intake is considered as a risk factor for osteoporosis. On the contrary an alkaline diet is known to have a beneficial influence on bone metabolism. Therefore the investigators hypothesized that an alkaline diet can reduce NaCl-induced bone resorption.

8 healthy male volunteers took part in a stationary study carried out in the metabolic ward of the German Aerospace Center. The study consisted of 2 campaigns, each lasting 16 days. Both campaigns were divided into 5 days of adaptation, 10 days of intervention and 1.5 days of stationary recovery. During the intervention period the volunteers diet was NaCl-rich (7.7 mmol Na/kg body weight/day) and supplemented in one campaign by 90 mmol potassium bicarbonate (KHCO3) in a randomized cross-over design. The other campaign served as control.

Bone metabolism was studied by bone formation markers in the fasting morning blood and 24h-urinary bone resorption markers. Acid base status was assessed by blood gas analyses in the fasted and the postprandial state as well as urinary markers. Protein turnover was studied with stable isotopes. Further physiological systems like energy metabolism and the cardiovascular system are also under investigation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Grade Metabolic Acidosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Campaign 1

Group Type EXPERIMENTAL

High NaCl + KHCO3

Intervention Type DIETARY_SUPPLEMENT

7.7 mmol Na/kgBW/d + 90 mmol KHCO3

Control: high NaCl

Intervention Type OTHER

7.7 mmol Na/kgBW/d

Campaign 2

Group Type EXPERIMENTAL

High NaCl + KHCO3

Intervention Type DIETARY_SUPPLEMENT

7.7 mmol Na/kgBW/d + 90 mmol KHCO3

Control: high NaCl

Intervention Type OTHER

7.7 mmol Na/kgBW/d

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High NaCl + KHCO3

7.7 mmol Na/kgBW/d + 90 mmol KHCO3

Intervention Type DIETARY_SUPPLEMENT

Control: high NaCl

7.7 mmol Na/kgBW/d

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy males
* 19 - 35 years
* 65 - 85kg
* 170 - 190 cm
* successfully completed psychological and medical screening

Exclusion Criteria

* athletes
* smoking
* drug- or alcohol abuse
* hyperlipidemia
* renal diseases
* obesity
* anemia
* bone diseases
* diabetes
* rheumatism
* blood donation within three month prior to study start
* participation in another clinical investigation three month prior to study start
Minimum Eligible Age

19 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Charite University, Berlin, Germany

OTHER

Sponsor Role collaborator

University of Erlangen-Nürnberg

OTHER

Sponsor Role collaborator

DLR German Aerospace Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

German Aerospace Center (DLR)

Cologne, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DLR Salty Life 8 Study

Identifier Type: -

Identifier Source: org_study_id